Showing results (61-70 of 110) with videos related to
Sort By:
Pageof 11
Pilot and Feasibility Studies|April 16, 2025
Recruitment rates, retention rates, and follow-up completion in a Brief Intervention and Contact trial for suicidal behavior: a feasibility studyDivya Soni, Balpreet Panesar, Alexander Dufort, et al.American Journal of Lifestyle Medicine|March 8, 2023
Lifestyle Behaviors, Depression, and Anxiety Among Individuals Living in Canada During the COVID-19 PandemicMario Simjanoski, Taiane de Azevedo Cardoso, Bianca Wollenhaupt-Aguiar, et al.International Journal of Molecular Imaging|December 11, 2013
Cholinergic Depletion in Alzheimer's Disease Shown by [ (18) F]FEOBV AutoradiographyMaxime J Parent, Marc-Andre Bedard, Arturo Aliaga, et al.Bjpsych Open|February 24, 2022
National suicide management guidelines recommending family-based prevention, intervention and postvention and their association with suicide mortality rates: systematic reviewBalpreet Panesar, Divya Soni, Mohammed I Khan, et al.Frontiers in Neurology|August 8, 2022
Reduced Metabotropic Glutamate Receptor Type 5 Availability in the Epileptogenic Hippocampus: An <i>in vitro</i> StudyMaria Zimmermann, Luciano Minuzzi, Arturo Aliaga Aliaga, et al.Bjpsych Open|April 2, 2025
Effects of vaping on physical and mental health in at-risk populations (VAPE): mixed-methods study of motivations for and perspectives on vaping in patients with opioid use disorderAlessia D'Elia, Balpreet Panesar, Nitika Sanger, et al.The Australian and New Zealand Journal of Psychiatry|February 15, 2019
Association of functioning and quality of life with objective and subjective measures of sleep and biological rhythms in major depressive and bipolar disorderAnastasiya Slyepchenko, Olivia R Allega, Xiamin Leng, et al.European Archives of Psychiatry and Clinical Neuroscience|May 28, 2017
A longitudinal study of neurotrophic, oxidative, and inflammatory markers in first-onset depression in midlife womenMatheus A Pasquali, Bernard L Harlow, Claudio N Soares, et al.Synapse (New York, N.Y.)|April 7, 2007
A PET study of effects of chronic 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on serotonin markers in Göttingen minipig brainPaul Cumming, Mette Møller, Kjeld Benda, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 26, 2008
Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine releaseBjörn H Schott, Luciano Minuzzi, Ruth M Krebs, et al.Pageof 11